Sahlgrenska Science Park is a unique hub for growth companies in the life science area in western Sweden.
Albireo is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. We have deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs.
ALS is a global leader in providing laboratory testing, inspection, certification and verification solutions. Assuring our community by providing high quality, innovative, professional testing services to help our clients make informed decisions.
BergmanLabora AB is one of the leading suppliers to the Swedish laboratory market. We provide instruments, microscopes, analysis and measuring instruments from world-leading suppliers. We perform technical service so that the equipment provides reliable results throughout its lifetime and conveys knowledge of applications and handling.
Founded in 2016, BICO is the leading bio convergence company in the world. By combining different technologies, such as robotics, artificial intelligence, computer science, and 3D bioprinting with biology, we enable our customers to improve people's health and lives for the better. We create the future of health.
Through image analysis of dental x-rays powered by A.I and a highly advanced communication platform, Boneprox bridges the gap between healthcare and dental care by detecting systemic diseases based on information from the dental care.
Calmino Group AB is a Swedish, science-driven innovative healthcare company with focus on Gut Health. Our vision is to successfully contribute towards improving health and well-being for people with digestive and gastrointestinal disorders.
CedoVision Artificial Intelligence® (CAI) is a software platform for developing AI applications in medical care. CAI® is optimized for 3D data from image management systems, e.g. CT and MRI scanners. We develop AI algorithms, custom applications for annotation and data processing as well as systems for network training.
Detectivio is a deep-tech company pioneering key enabling technologies for contactless vital signs measurement. Contactless vital signs – anywhere and anytime; for emergency departments, telemedicine, vehicles, events, offices, home-care, and beyond…
Detectivio has developed technology for contact-free detection and quantification of vital signs by scanning the face from a one-meter distance (four feet). The technology's unique potential comes from implementing and adding automatic contactless measurements in situations where it was previously impossible.
Dizlin Pharmaceuticals is a pharmaceutical research company developing new treatments for Parkinson´s disease. The company’s basic research is undertaken in collaboration with the University of Gothenburg and Linköping University in Sweden. Our business model comprises development of products for the treatment of Parkinson´s disease and to license these to pharmaceutical companies active in this field.
Elypta is a molecular diagnostics company focused on reducing cancer mortality through early detection. Elypta is pioneering a metabolism-based liquid biopsy and measures the GAGome – system biomarkers of tumor metabolism. Machine learning algorithms are then used to detect signatures of cancer noninvasively. Elypta is advancing a broad clinical program across different cancers with the first indication expected to be early detection of recurrence in renal cell carcinoma.
Everdrone offers advanced drone operations as a service. The company’s first service to reach the market enables emergency dispatch organisations to deliver life-critical equipment by drone, e.g. a defibrillator in case of out-of-hospital cardiac arrest. The company's test and development facilities are located at Säve Airport near Gothenburg. Everdrone also actively works with regulatory issues associated with drones, specializing in urban operations.
Eyescanner is an AI-based software that detects the influence of drugs through image analysis of the eye area. This is done by filming a sequence on a person’s eye. Eyescanner is both faster, easier and less intrusive than other traditional methods such as saliva or urine tests.
It is clear that drugs affect the central nervous system, which for example is reflected in the eye’s reaction and movement patterns. Our software finds and analyzes a number of scientifically proven measurement values in the eye area that are significant for drug influence.
Galecto is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer.
Getica is a biotechnology company specialized in protein purification for supporting the immunodiagnostics industry. We are also engaged in several research projects aiming towards putting new innovative diagnostic tests on the market.
Gnosco offer a digital diagnostic support platform for faster and more secure diagnosis of skin lesions and wounds. The CE-certified platform, Dermicus, provides a faster and more efficient medical process, improved patient experience and is specifically aimed for communication between healthcare providers. In addition, Dermicus is also a continuous E-learning platform for doctors and nurses. Total costs are decreased due to fewer excisions and less physical referrals to specialists, but most important diagnoses are set much faster than before.
InfoGov Sweden AB is a consultancy specialising in Innovation, Collaboration, and Facilitation services within the life sciences. We work with our clients to perfect their approach to innovation whether it be to generate novel ideas, or bring new products, services, and processes to life. Facilitation tends to be required where there are high-levels of complexity, a diverse range of views, and perhaps some degree of conflict. Bespoke collaborations are designed to meet our clients' needs, then delivered at F2F and virtual events.
Insplorion AB, with its disruptive sensor platform NanoPlasmonic Sensing (NPS), operates within four fields;. air quality sensors, hydrogen sensors, battery sensors and research instruments. The sensors are small, durable and cost efficient at volume production. Our sensor technology enables air quality sensors at home, in cars and in public environment, Our hydrogen sensors show a sub-second response time, making them the fastest in the world and will promote the growth of hydrogen infrastructure. The battery sensor optimizes battery control and usage. Our instruments give scientists around the world nanometer sensitive real time data of surface processes in fields like catalysis, material- and life science.
InvivoPower provides a disruptive transcutaneous wireless energy link technology for implanted heart pumps and total artificial hearts. The technology is characterized by its high energy transfer efficiency and solves the Achilles heel for the treatment using heart pumps and artificial hearts: driveline infections. Driveline is the power cable that supplies energy to the artificial hearts and which is very prone to infections. Driveline infections is also the number one cause for readmitting the patient to the hospital.
IRLAB is a research and development company that focuses on developing novel treatments in Parkinson’s disease. The most advanced candidates, mesdopetam and pirepemat, both of which completed Phase IIa studies, intends to treat some of the most difficult symptoms related to Parkinson's: dyskinesias (PD-LIDs), psychosis (PD-P) and impaired balance leading to falls (PD-Falls). Through the proprietary research platform, ISP, IRLAB discovers and develops unique drug candidates for central nervous system (CNS) related disorders where large and growing medical need exist. In addition to the clinical candidates, the ISP platform has also generated several CNS programs that are now in preclinical phase.
Isofol Medical AB (publ) is a clinical stage biotech company developing arfolitixorin to improve the efficacy of standard of care chemotherapy for advanced colorectal cancer by increasing tumor response and progression free survival. Isofol holds a worldwide exclusive license agreement with Merck KGaA, Darmstadt, Germany to develop and commercialize arfolitixorin for oncology indications. Isofol Medical AB (publ) is traded on the Nasdaq First North Premier Growth Market. Certified Adviser is FNCA Sweden AB.
Far too many people don't live the life they deserve. They sit.
Especially those who need extra support to cope with their everyday lives, example due to dementia. Dementia causes a sedentary lifestyle. Physical activity is a major factor for everyday wellbeing and long-term health.
Today there are already 50 million people worldwide with dementia, and it’s growing with ageing populations.
Our mission is to help create more activity with the power of personal music. Our innovation is utilising the universal effect music has on humans. Music side-steps cognitive barriers and lights up memories, emotions and the lust for activity.
Key2Compliance focuses on helping companies in the medical device and pharmaceutical industry. We are a full-service partner that offers complete solutions in all aspects of our customers' needs, including but not limited to training in regulations, consultation, and compliance.
Konsert Strategy & IP is a boutique management consulting firm constantly breaking new ground as the world’s premier catalyst of technology and intellectual property value. We partner with technology-intensive organizations across the globe to strengthen their growth and profitability. Our team cooperates at all levels of client organizations, developing teams and individuals, and changes the culture with new skills and behaviours. With a Swedish home base, we work with technology companies globally and our client list includes everything from cutting-edge growth ventures to the world’s largest companies.
Lif is the industry organization for the researching pharmaceutical companies in Sweden. We work for high-quality care and access to new treatments by strengthening the Swedish Life Science sector in collaboration with the healthcare actors, politicians, officials and patient representatives.
Our companies researches and develops medical innovations - new products and services that prevent, diagnose, treat and follow up diseases and other medical conditions. They also improve the quality of life for patients by contributing to the development of the Swedish healthcare system, partly through joint research, and partly through education and training for the correct use of innovative medicines and vaccines.
Medfield is developing artificial intelligence and microwave-based decision support instruments and tools, primarily to examine patients with brain injuries, which can be used by healthcare professionals both inside and outside hospitals. Customers are from ambulance markets, health care facilities far away from qualified university hospitals and advanced emergency departments who need support to act quickly when dealing with neuro injuries.
MediCase provides an eCRF (Electronic Case Report Form), an easy and efficient tool for collecting, validating, and managing data in clinical trials. MediCase eCRF is developed by a team of clinically active researchers and physicians, clinical data managers, and professional software developers. It has from day one been designed with focus on the researcher and the study site – both when it comes to functionality, user friendliness, and not least cost and the pricing model.
MYoroface AB is a research driven MedTech company that has developed and patented the neuromuscular training device IQoro which can give improved quality of life to millions of people. IQoro treats the underlying causes of conditions like reflux, snoring and eating and swallowing difficulties. 90 seconds’ training per day gives a proven effect.
Neoss offers intelligent products that are intuitively simple to use. Our products allow dental professionals to provide reliable and cost-effective treatments to their patients with excellent long-term results.
MedTech20® is a method including a survey measuring the everyday quality-of-life of patients (Lesén et al, 2017). The questions are scientifically validated and can be applied to all types of products used by patients with any type of disease/disability. It can be used in various phases in the product’s lifecycle including documentation of User Experiences according to MDR. The results of the survey (MedTech20®Questionnaire) can be transformed into an index (MedTech®Index) that may be used in cost-effectiveness analyses.
MedTech20® is digitalized from collection of patient-level responses to analyses of data, meaning results are delivered immediately after completion of the study.
Njord Medtech's mission is to improve the quality of patient care and increase clinical productivity on a global basis. The first goal is to commercially launch a motorized lateral patient transfer device to improve work environment and x-ray productivity, mainly targeted at specialist care departments.
Oblique Therapeutics AB is a privately held Swedish biotech company developing innovative new medicines for severe diseases with a large unmet medical need focusing on pain and aggressive metastatic cancer. The company uses Abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome.
Opatus provides a complementary neuropsychiatric tool, Opatus CPTA, for simultaneous measurements of Attention, Impulsivity and Activity; the three core symptoms of ADHD.
We make it possible to administrate a full attention test, usually requiring physical visit at a clinic, from a distance e.g. the home or school.
Opatus CPTA increases diagnosis precision and is easy to use, quick, cost effective and accessible.
Users are psychologists/psychiatrists and doctors in public or private child, adolescent, and adult psychiatry
for attention assessment and follow-up dose titration. The tool is also used in research.
PeckiiLess is a Sweden-based company that has created a nano-sensor that can detect blood glucose levels through human exhalation to an extremely accurate level. Hundreds of millions of people, most diabetics, around the world rely on accurate glucose monitoring to lead a healthy life. Current methods are invasive can be painful, are expensive, wasteful and not universally available. Using the PeckiiLess sensor, we can improve the lives of these people, reduce costs and eliminate the waste of the current blood glucose monitoring methods. PeckiiLess is good for people, the planet and pocketbooks.
PExA is a Swedish award-winning company that develops and delivers a breakthrough solution that address the rising need for biomarker identification and early diagnosis of lung disease through a technology enabling non-invasive sampling of human small airways.
PharmaRelations is the Nordic market leader within talent services for the life science industry. We specialize in partnering with some of the top and most innovative organizations exclusively in the Life Science sector across our region.
ResearchOnTheGo is redefining how the medical device industry interacts with end-users. We help companies reduce costs for clinical investigations and combine several sources of information into a cohesive post-market follow-up plan. By taking a unique user-centric approach to regulatory compliance, ResearchOnTheGo helps companies meet the requirements of the new MDR regulation cheaper and faster. This innovative approach helps companies go beyond regulatory compliance to create truly innovative products that address the needs and wishes of real users. ResearchOnTheGo is your partner for growth and success in the medical device industry of the future.
RISE Research Institutes of Sweden is Sweden’s research institute and innovation partner. Through international collaboration with industry, academia and the public sector, we ensure business competitiveness and contribute to a sustainable society.
SAFEGUARD Medical consist of five different brands, Combat Medical, Prometheus Medical, Water-Jel, SIMBODIES and H&H. All brands share a common vision for the safety of the people in the face of an emergency. We care about people and exist to bring together life-saving products and knowledge of emergency medical skills that preserve life. We provide emergency medical equipment and high-quality courses and training for a wide customer group. In addition to our own product portfolio, we are also the distributor for corpuls in Norway and Sweden, and deliver training, service/repair, and consumables to all corpuls products.
Salus mea is the only certified mobile telecare service in Europe. The service helps its users feel safe both at home and outdoors. To feel safe, to be independent and to be a part of the community is a basic right and a requirement of the Social Services Act.
Salus mea’s user centric approach meets the needs of its users through the integration of third party services. It provides the opportunity for individual adaptation, using modern, simple and discreet support through all phases of aging.
Scandinavian CRO is a leading full-service contract research organization. We provide expert support that enables you to succeed in your clinical studies.
SCRO has a team of dedicated professionals with decades of experience. Whether you’re developing a pharmaceutical, medical device, IVD or biologic, we have the expertise and drive to support you with custom solutions that fit your clinical research journey.
We support pharmaceutical, biotech and medical device companies as well as academic researchers to design and conduct their clinical research – from carrying out clinical trials to developing an entire clinical program.
Simsen Diagnostics’ vision is to maximize the potential of ultrasensitive sequencing for improved healthcare and novel applications. Our unique technology enables sensitive detection of cancer mutations by a simple blood sample. This allows precision medicine to be applied to more patients and monitoring of the disease over time. Compared to other technologies for ultrasensitive sequencing, our solutions are both simple to use and specifically adapted for the analysis of difficult to analyze DNA. Customers include laboratories, pharmaceutical companies, and hospitals.
Takara Bio Europe AB, formerly Cellartis AB, is focusing on stem cell-derived products and services for cell therapy/regenerative medicine, drug discovery, and disease modeling. The company leverages its long-standing experience in stem cell handling and scale-up together with leading expertise in the differentiation of stem cells into mature and functional human cells. Specifically, the company possesses broad expertise in human pluripotent stem cells, including both hiPS and hES cells and related media. Our GMP facility, located in Göteborg, Sweden, operates under a manufacturing license for the establishment and banking of clinical-grade hES cell lines and is being expanded for the manufacturing of GMP-grade cell culture media.
Toleranzia develops drugs that use the immune system’s intrinsic power to treat orphan (rare) autoimmune diseases. The drugs, which target the cause of the disease, can cure or greatly alleviate the disease and not, like current treatments, only reduce the symptoms. They have the potential to become the first long-acting or curative treatments that act specifically on the underlying cause of the disease. Toleranzia develops the drug candidate TOL2 against the autoimmune nerve and muscle disease myasthenia gravis and the drug candidate TOL3 against the autoimmune blood vessel disease ANCA vasculitis. Both diseases are orphan diseases that have a huge unmet medical need and a great market potential.
VERIGRAFT AB is a Swedish biotechnology company run by experienced entrepreneurs and mastering a unique, breakthrough technology in the field of advanced therapies and regenerative medicine. We make transplantation possible without the severe risks of immunosuppression, and develop advanced therapies and tissue engineered products that will be able to help millions of patients with serious diseases.
Vita Verita provides products and services to laboratories, cleanrooms and critical environments.
We cooperate with well known suppliers and have our own branded production of single use garments and wipes.
VoiceMed is an innovative medical device software that allows early disease’s detection and health status monitoring through sound analysis. Our solution is available on any smartphone, from everywhere.
VoiceMed aims to simplify healthcare access with rapid and accurate disease screening, based on voice, cough and breathing, while driven by the vision of empowering people to know their health status with a medical and scientifically validated solution.
Our first product is a software which gives companies the possibility to early detect COVID19 and further monitor the health status of their employees remotely, with an easy to use, cost-effective and fast solution.